Q3 2025 Holdings
Filed 2025-11-14 | 32 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $324.0M | 3,007,164 | 27.0% |
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $171.1M | 6,707,165 | 14.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $123.6M | 2,647,333 | 10.3% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $100.8M | 77,558,856 | 8.4% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $77.6M | 1,780,000 | 6.5% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $59.2M | 11,341,381 | 4.9% |
| Illumina Inc(ILMN) | COM | 452327109 | $49.9M | 525,000 | 4.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $43.5M | 1,555,000 | 3.6% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $38.8M | 1,600,000 | 3.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $25.1M | 55,000 | 2.1% |
| Tempus AI Inc(TEM) | CL A | 88023B103 | $23.7M | 294,127 | 2.0% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $22.4M | 1,295,361 | 1.9% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $19.7M | 758,857 | 1.6% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $17.5M | 3,167,175 | 1.5% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $16.1M | 1,600,000 | 1.3% |
| Hims & Hers Health Inc(HIMS) | COM CL A | 433000106 | $13.0M | 230,000 | 1.1% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $12.9M | 890,000 | 1.1% |
| Septerna Inc(SEPN) | COM | 81734D104 | $10.4M | 553,268 | 0.9% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $9.5M | 276,308 | 0.8% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $8.6M | 25,000 | 0.7% |
| Incyte Corp(INCY) | COM | 45337C102 | $8.5M | 100,000 | 0.7% |
| Guardant Health Inc(GH) | COM | 40131M109 | $6.2M | 100,000 | 0.5% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $4.9M | 90,000 | 0.4% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $3.3M | 282,312 | 0.3% |
| Absci Corporation(ABSI) | COM | 00091E109 | $3.0M | 973,260 | 0.2% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $1.7M | 148,333 | 0.1% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $926.4K | 723,767 | 0.1% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $806.8K | 165,323 | 0.1% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $637.4K | 86,014 | 0.1% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $611.6K | 1,228,190 | 0.1% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $586.4K | 361,969 | 0.0% |
| Ginkgo Bioworks Holdings Inc(DNA) | CL A NEW | 37611X209 | $532.1K | 36,493 | 0.0% |